BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31291579)

  • 1. SAMHD1 Modulates Early Steps during Human Cytomegalovirus Infection by Limiting NF-κB Activation.
    Kim ET; Roche KL; Kulej K; Spruce LA; Seeholzer SH; Coen DM; Diaz-Griffero F; Murphy EA; Weitzman MD
    Cell Rep; 2019 Jul; 28(2):434-448.e6. PubMed ID: 31291579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus overcomes SAMHD1 restriction in macrophages via pUL97.
    Businger R; Deutschmann J; Gruska I; Milbradt J; Wiebusch L; Gramberg T; Schindler M
    Nat Microbiol; 2019 Dec; 4(12):2260-2272. PubMed ID: 31548682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAF6 and TAK1 Contribute to SAMHD1-Mediated Negative Regulation of NF-κB Signaling.
    Espada CE; St Gelais C; Bonifati S; Maksimova VV; Cahill MP; Kim SH; Wu L
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAMHD1 suppresses innate immune responses to viral infections and inflammatory stimuli by inhibiting the NF-κB and interferon pathways.
    Chen S; Bonifati S; Qin Z; St Gelais C; Kodigepalli KM; Barrett BS; Kim SH; Antonucci JM; Ladner KJ; Buzovetsky O; Knecht KM; Xiong Y; Yount JS; Guttridge DC; Santiago ML; Wu L
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3798-E3807. PubMed ID: 29610295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAMHD1 phosphorylation and cytoplasmic relocalization after human cytomegalovirus infection limits its antiviral activity.
    De Meo S; Dell'Oste V; Molfetta R; Tassinari V; Lotti LV; Vespa S; Pignoloni B; Covino DA; Fantuzzi L; Bona R; Zingoni A; Nardone I; Biolatti M; Coscia A; Paolini R; Benkirane M; Edfors F; Sandalova T; Achour A; Hiscott J; Landolfo S; Santoni A; Cerboni C
    PLoS Pathog; 2020 Sep; 16(9):e1008855. PubMed ID: 32986788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The host antiviral protein SAMHD1 suppresses NF-κB activation by interacting with the IKK complex during inflammatory responses and viral infection.
    Yang H; Espada CE; Phillips S; Martinez N; Kenney AD; Yount JS; Xiong Y; Wu L
    J Biol Chem; 2023 Jun; 299(6):104750. PubMed ID: 37100289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phorbol ester-induced human cytomegalovirus major immediate-early (MIE) enhancer activation through PKC-delta, CREB, and NF-kappaB desilences MIE gene expression in quiescently infected human pluripotent NTera2 cells.
    Liu X; Yuan J; Wu AW; McGonagill PW; Galle CS; Meier JL
    J Virol; 2010 Sep; 84(17):8495-508. PubMed ID: 20504934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter.
    DeMeritt IB; Milford LE; Yurochko AD
    J Virol; 2004 May; 78(9):4498-507. PubMed ID: 15078930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of SAMHD1 Restriction Factor Through Cullin-Ring E3 Ligase Complexes During Human Cytomegalovirus Infection.
    Hyeon S; Lee MK; Kim YE; Lee GM; Ahn JH
    Front Cell Infect Microbiol; 2020; 10():391. PubMed ID: 32850489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphasic regulation of A20 gene expression during human cytomegalovirus infection.
    Gu SY; Kim YE; Kwon KM; Han TH; Ahn JH
    Virol J; 2014 Jul; 11():124. PubMed ID: 25005727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RICK activates a NF-kappaB-dependent anti-human cytomegalovirus response.
    Eickhoff J; Hanke M; Stein-Gerlach M; Kiang TP; Herzberger K; Habenberger P; Müller S; Klebl B; Marschall M; Stamminger T; Cotten M
    J Biol Chem; 2004 Mar; 279(10):9642-52. PubMed ID: 14670961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters.
    Yurochko AD; Mayo MW; Poma EE; Baldwin AS; Huang ES
    J Virol; 1997 Jun; 71(6):4638-48. PubMed ID: 9151857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replication.
    Kapoor A; Forman M; Arav-Boger R
    PLoS One; 2014; 9(3):e92704. PubMed ID: 24671169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexamethylene bisacetamide can convert nonpermissive human cells to a permissive state for expressing the major immediate-early genes of human cytomegalovirus by up-regulating NF-kappaB activity.
    Kitagawa R; Takahashi Y; Takahashi M; Imazu H; Yasuda M; Sadanari H; Tanaka J
    Virology; 2009 Jan; 383(2):195-206. PubMed ID: 19027925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human cytomegalovirus virion possesses an activated casein kinase II that allows for the rapid phosphorylation of the inhibitor of NF-kappaB, IkappaBalpha.
    Nogalski MT; Podduturi JP; DeMeritt IB; Milford LE; Yurochko AD
    J Virol; 2007 May; 81(10):5305-14. PubMed ID: 17344282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abemaciclib restricts HCMV replication by suppressing pUL97-mediated phosphorylation of SAMHD1.
    Syrigos GV; Feige M; Dirlam A; Businger R; Gruska I; Wiebusch L; Hamprecht K; Schindler M
    Antiviral Res; 2023 Sep; 217():105689. PubMed ID: 37516154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression.
    DeMeritt IB; Podduturi JP; Tilley AM; Nogalski MT; Yurochko AD
    Virology; 2006 Mar; 346(1):15-31. PubMed ID: 16303162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome inhibitors: a novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation.
    Prösch S; Priemer C; Höflich C; Liebenthaf C; Babel N; Krüger DH; Volk HD
    Antivir Ther; 2003 Dec; 8(6):555-67. PubMed ID: 14760889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Cytomegalovirus DNA Polymerase Subunit UL44 Antagonizes Antiviral Immune Responses by Suppressing IRF3- and NF-κB-Mediated Transcription.
    Fu YZ; Su S; Zou HM; Guo Y; Wang SY; Li S; Luo MH; Wang YY
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. U
    Goodwin CM; Schafer X; Munger J
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.